UPDATE: SunTrust Starts Axonics Modulation Technologies Inc. (AXNX) at Buy

(updating comment, analyst name)

SunTrust analyst Kaila Krum initiates coverage on Axonics Modulation Technologies Inc. (NASDAQ: AXNX) with a Buy rating and a price target of $38.00.

The analyst comments "Axonics has had a fully staffed salesforce since mid-2019, and has pinpointed about 1,000 high-volume surgeons within the U.S. Our review of the company’s social media announcements suggest that over 40 surgeons are now using the Axonics system in their practice – which should give comfort in the early traction behind the launch."

For an analyst ratings summary and ratings history on Axonics Modulation Technologies Inc. click here. For more ratings news on Axonics Modulation Technologies Inc. click here.

Shares of Axonics Modulation Technologies Inc. closed at $27.46 yesterday.

You May Also Be Interested In

• Wells Fargo Starts Vivmark Residential (VMRK) at Overweight, 'Setting the mark for growth'
• Deere (DE) PT Raised to $585 at JPMorgan
• Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'